(Reuters Health)—Doctors who receive payments or gifts from pharmaceutical companies are more likely to prescribe brand name medications, a new study suggests. Dr. James Yeh, of Brigham and Women’s Hospital in Boston, and colleagues write May 9 online in JAMA Internal Medicine that some states require doctors to report what they receive from drug companies….
Rheumatology Research Foundation Launches #RheumLife
May is recognized as National Arthritis Awareness Month, a time to bring attention to the more than 46 million Americans living with arthritis and related inflammatory diseases. In honor of the occasion, the Rheumatology Research Foundation is launching #RheumLife, a social media campaign to bring awareness to the severity of rheumatic disease. Through Twitter and…
Rheumatologist Shares Lessons Learned in 20 Years as Program Director
When I came to Washington University School of Medicine (WUSM) in St. Louis in 1996 to become fellowship program director, the previous program director had left, and the two fellows who had been selected both backed out (this was before the match). I was handed a stack of manila folders, which contained the previous documentation….
Participate in Virtual Hill Meetings through the ACR
On May 12, ACR leaders representing the Board of Directors, the Affiliate Societies Council and the Committees on Government Affairs and RheumPAC took the ACR’s policy message to Capitol Hill. There is power in numbers, so we hope you will participate in your own Virtual Hill Day by visiting Legislative Action Center and letting your…
Treating Rheumatologic Illnesses in Athletes
Never underestimate the power of dreams and the influence of the human spirit. … The potential for greatness lives within each of us. —Wilma Rudolph, U.S. Olympic sprinter & winner of three gold medals From Spinnaker to Wheelchair It can be an unnerving experience when the patient you are about to see is young and…
Concerns Arising over Increased Retractions in Scientific Articles
The number of scientific articles retracted increased 10-fold between 1988 and 2008 (from 0.002% in the early 1980s to 0.02% in 2005–2009), according to a paper published in the Journal of Medical Ethics.1 The authors did note that the number of articles listed in Medline each year has also increased over time, from approximately 300,000…
Biosimilars: Expanded Treatment Options
Soon, biosimilars will be available as treatment options for our patients. Biosimilars are being introduced to the U.S. market in the hope that they will spur competition and drive down the price of these expensive medicines. Previous articles in The Rheumatologist have touched on various issues surrounding these new therapies, and everyone in the rheumatology…
Rheumatologists on the Move, May 2016
Associate Editor of The Rheumatologist on Working Sabbatical Maura Daly Iversen, PT, DPT, SD, MPH, professor and chair of the Department of Physical Therapy, Movement, and Rehabilitation Sciences at Northeastern University, a behavioral scientist in the Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital, a lecturer at Harvard Medical School, Boston, and…
Rheumatologist Amanda Nelson, MD, MSCR, Walks with Patients to Encourage Physical Activity
“No more excuses.” At least, that’s what Amanda Nelson, MD, MSCR, now tells her patients. As a rheumatologist, assistant professor in the School of Medicine at the University of North Carolina at Chapel Hill (UNC) and clinical researcher at UNC’s onsite Thurston Arthritis Research Center, Dr. Nelson says patients often provide a litany of legitimate—and sometimes…
State of RheumPAC: 2015 Annual Report
Dear Friends and Colleagues, With your strong support and commitment, RheumPAC has grown again for the eighth straight year, allowing us to do even more on your behalf. Not only did we exceed our original goal by raising more than $150,000. More importantly, these donations came from nearly 350 ACR and ARHP members—a new record….
- « Previous Page
- 1
- …
- 129
- 130
- 131
- 132
- 133
- …
- 229
- Next Page »